Johnson Matthey (OTCMKTS:JMPLY) Stock Rating Lowered by Zacks Research

Johnson Matthey (OTCMKTS:JMPLY) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Thursday,Zacks.com reports.

Other analysts have also recently issued reports about the stock. Citigroup reiterated a “neutral” rating on shares of Johnson Matthey in a research note on Tuesday, October 21st. Jefferies Financial Group raised Johnson Matthey to a “strong-buy” rating in a report on Thursday, October 9th. One research analyst has rated the stock with a Strong Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Johnson Matthey Stock Performance

Shares of JMPLY traded up $0.34 during trading hours on Thursday, reaching $55.95. 1,868 shares of the company traded hands, compared to its average volume of 3,191. The stock’s fifty day moving average price is $54.59 and its 200 day moving average price is $48.56. Johnson Matthey has a 12-month low of $29.01 and a 12-month high of $58.40. The company has a quick ratio of 1.01, a current ratio of 1.42 and a debt-to-equity ratio of 0.57.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.